+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 72 Pages
  • June 2025
  • Region: Global
  • GlobalData
  • Charles River
  • ID: 1648587
Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Charles River Laboratories International Inc (Charles River), is a contract research organization (CRO) that provides essential products and services to accelerate research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The company also offers clinical, manufacturing and operations and staffing support. It provides solutions focused on therapy areas related to cardiovascular, central nervous system, metabolic, inflammation, oncology, ophthalmology, respiratory, and musculoskeletal disorders. Charles River provides products and services to pharmaceutical and biotechnology companies, government agencies, hospitals and academic institutions. Charles River is headquartered in Wilmington, Massachusetts, the US.

Charles River Laboratories International Inc Key Recent Developments

  • Jun 16, 2025: Charles River Laboratories International Announces Recycling Program
  • May 28, 2025: Charles River and CHDI Foundation Announce Extension of Drug Discovery Partnership
  • Apr 29, 2025: Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort
  • Apr 22, 2025: Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Charles River Laboratories International Inc - Key Facts
  • Charles River Laboratories International Inc - Key Employees
  • Charles River Laboratories International Inc - Key Employee Biographies
  • Charles River Laboratories International Inc - Major Products and Services
  • Charles River Laboratories International Inc - History
  • Charles River Laboratories International Inc - Company Statement
  • Charles River Laboratories International Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Charles River Laboratories International Inc - Business Description
  • Business Segment: Discovery and Safety Assessment
  • Overview
  • Performance
  • Business Segment: Manufacturing
  • Overview
  • Performance
  • Business Segment: Research Models and Services
  • Overview
  • Performance
  • Geographical Segment: Asia Pacific
  • Performance
  • Geographical Segment: Canada
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Other
  • Target Markets
  • Performance
  • Geographical Segment: US
  • Performance
  • Charles River Laboratories International Inc - Corporate Strategy
  • Charles River Laboratories International Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Charles River Laboratories International Inc - Strengths
  • Charles River Laboratories International Inc - Weaknesses
  • Charles River Laboratories International Inc - Opportunities
  • Charles River Laboratories International Inc - Threats
  • Charles River Laboratories International Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
  • Charles River Laboratories International Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 16, 2025: Charles River Laboratories International Announces Recycling Program
  • May 28, 2025: Charles River and CHDI Foundation Announce Extension of Drug Discovery Partnership
  • Apr 29, 2025: Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort
  • Apr 22, 2025: Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development
  • Apr 15, 2025: Promega HiBiT-PsVLP Bioassay to Aid Global Vaccine Research
  • Apr 02, 2025: CAS and Charles River Laboratories International Announce Expansion of Collaboration
  • Mar 25, 2025: Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica, an AI-Powered Drug Discovery Platform
  • Mar 18, 2025: Oribiotech Announces Launch of Preferred Partner Network
  • Feb 25, 2025: SGH and Charles River team up for CGMP cell banking services
  • Feb 25, 2025: Charles River Signs Agreement With Singapore General Hospital
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Charles River Laboratories International Inc, Key Facts
  • Charles River Laboratories International Inc, Key Employees
  • Charles River Laboratories International Inc, Key Employee Biographies
  • Charles River Laboratories International Inc, Major Products and Services
  • Charles River Laboratories International Inc, History
  • Charles River Laboratories International Inc, Subsidiaries
  • Charles River Laboratories International Inc, Key Competitors
  • Charles River Laboratories International Inc, Ratios based on current share price
  • Charles River Laboratories International Inc, Annual Ratios
  • Charles River Laboratories International Inc, Interim Ratios
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
  • Charles River Laboratories International Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Charles River Laboratories International Inc, Performance Chart (2020 - 2024)
  • Charles River Laboratories International Inc, Ratio Charts
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Corgenix Medical Corp
  • Pharmaceutical Product Development LLC
  • IMR Partner International Medical Research GmbH
  • The Jackson Laboratory
  • Almac Group Ltd
  • Labcorp Drug Development
  • MLM Medical Labs GmbH
  • BioReliance Corp